Effect of diuretic therapy on hypertensive left ventricular hypertrophy

B M Massie1

  • 1University of California, San Francisco.

European Heart Journal
|December 1, 1992
PubMed

Insights

Left ventricular hypertrophy (LVH) is a risk for heart problems in hypertension. This review examines if diuretics effectively regress LVH, considering blood pressure control and study limitations.

Area of Science:

  • Cardiology
  • Hypertension Research

Background:

  • Left ventricular hypertrophy (LVH) is a significant independent risk factor for cardiovascular morbidity in essential hypertension.
  • Antihypertensive drug therapy is known to induce regression of LVH in many patients.

Purpose of the Study:

  • To critically evaluate the efficacy of antihypertensive agents, particularly diuretics, in regressing LVH.
  • To determine if LVH regression is drug-specific or primarily driven by blood pressure control.

Main Methods:

  • Review of major clinical trials and echocardiographic studies on LVH regression.
  • Critical analysis of study methodologies, including controls, blinding, duration, sample size, and patient selection.
  • Examination of data regarding electrocardiographic and echocardiographic manifestations of LVH.

Main Results:

  • Major trials show consistent reversal of electrocardiographic LVH with diuretic therapy.
  • Echocardiographic study results on LVH regression with diuretics are variable and often limited by methodological flaws.
  • Lack of universal agreement on the influence of diuretics on LVH regression.

Conclusions:

  • The effectiveness of diuretics in regressing echocardiographic LVH remains debated due to inconsistent and flawed evidence.
  • Further well-controlled studies are needed to definitively assess the role of diuretics and other antihypertensives in LVH regression.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...